Vaccines: Discovery & Development, Cologne, Germany

Vaccines: Discovery and Development presents advances in enhancing immunogenicity including the latest developments in adjuvants, vectors, delivery, formulation, t-cell epitope modification and, for cancer vaccines, the breaking of tolerance.

Based on in-depth research with leaders in the field along with potential delegates, Vaccines: Discovery and Development brings together over 31 industry expert speakers presenting 27 case studies to reveal how you can achieve the full potential of your vaccines.

Key reasons to attend:

• Discover the latest thinking on immunological mechanisms behind vaccines and adjuvants


• Learn about recent developments with adjuvants including TLR agonists, MF39 and cationic liposome adjuvants


• Analyse the real advances in transcutaneous immunisation


• Review cutting-edge characterisation technologies


• Industry experts will reveal what they have discovered in their efforts to stimulate the immune response and overcome tolerance for therapeutic vaccines


• Find out the latest developments in proof of concept and immune correlates for therapeutic vaccines

Further Information: http://www.iir-events.com/IIR-Conf/page.aspx?id=9522